News

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Top officials for the Food and Drug Administration laid out new requirements for yearly updates to COVID shots, saying they’d ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines for Americans — a move that will ...
The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...